Page last updated: 2024-09-02

thromboxanes and Stroke

thromboxanes has been researched along with Stroke in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, KL; Chin-Dusting, JPF; Dragoljevic, D; Gaspari, T; Jefferis, AM; Jennings, GL; Khan, SI; Lee, MKS; Moore, XL; Murphy, AJ; Shihata, WA; Vinh, A1
Knights, KM; Mangoni, AA1
Dippel, DW; Koudstaal, PJ; Leebeek, FW; Li, SS; Mehicevic, A; Van Kooten, F; van Vliet, HH1
Basili, S; Ciabattoni, G; Cipollone, F; Davì, G; Di Franco, M; Ferro, D; Roccaforte, S1
Eikelboom, JW; Hirsh, J; Johnston, M; Weitz, JI; Yi, Q; Yusuf, S1

Reviews

1 review(s) available for thromboxanes and Stroke

ArticleYear
[Non-steroidal anti-inflammatory drugs and risk of stroke in older patients: current controversies and research directions].
    Giornale italiano di cardiologia (2006), 2011, Volume: 12, Issue:5

    Topics: Age Factors; Aged; Aged, 80 and over; Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Comorbidity; Cyclooxygenase 2 Inhibitors; Disease Progression; Drug Interactions; Edema; Epoprostenol; Evidence-Based Medicine; Forecasting; Humans; Hypertension; Kidney; Research; Risk; Stroke; Thrombophilia; Thromboxanes

2011

Trials

2 trial(s) available for thromboxanes and Stroke

ArticleYear
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke?
    Cerebrovascular diseases (Basel, Switzerland), 2004, Volume: 17, Issue:4

    Topics: Adult; Aged; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Patient Compliance; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thromboxane B2; Thromboxanes; Treatment Outcome

2004
Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus.
    Arthritis and rheumatism, 1999, Volume: 42, Issue:12

    Topics: Adult; Antibodies, Antiphospholipid; Antigens; Aspirin; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Humans; Ischemia; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Stroke; Thromboxane B2; Thromboxanes; Tissue Plasminogen Activator; Venous Thrombosis; von Willebrand Factor

1999

Other Studies

3 other study(ies) available for thromboxanes and Stroke

ArticleYear
Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:1

    Topics: Adaptive Immunity; Angiotensin II; Animals; Aspirin; Biomarkers; Blood Pressure; Blood Vessels; Cardiomegaly; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Disease Susceptibility; Dose-Response Relationship, Drug; Epoprostenol; Hypertension; Kidney; Mice; Rats; Rats, Inbred SHR; Real-Time Polymerase Chain Reaction; RNA, Messenger; Stroke; Systole; T-Lymphocytes; Thromboxanes

2019
Aspirin resistance: a worry?
    The Johns Hopkins medical letter health after 50, 2005, Volume: 16, Issue:11

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Drug Resistance; Fibrinolytic Agents; Humans; Myocardial Infarction; Stroke; Thromboxanes

2005
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
    Circulation, 2002, Apr-09, Volume: 105, Issue:14

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors; Death, Sudden, Cardiac; Demography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thromboxane B2; Thromboxanes; Vitamin E

2002